ArticleInsects2024
The Phytochemical Properties of Low-Grade Longan Syrup and Its Potential Use as a Dietary Supplement for Honey Bees.
Article in Insects, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Editorial for theInsects · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Climate change significantly affects honey bee populations and their access to natural food sources, demanding alternative economic feed sources. Longan stands out as the most important fruit crop in Southeast Asia, but with a surplus of low-grade fruit that is not suitable for the market. This study investigates the potential of longan syrup as an alternative carbohydrate source for honey bees by measuring sugar composition, phytochemical profiles, feed, and survival, as well as the resulting gut microbial changes. Processed longan syrup contains 8.2, 85.1, and 33.1 mg/g of sucrose, glucose, and fructose. Total phenolic and flavonoid contents were 24.94 and 129.78 mg/g, respectively, showing a 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical inhibition rate of 26.78% and an 87.82% antiradical activity rate via 2,2'-azino-bis (3-ethylbenzothiazoline-6-sulfonic acid) (ABTS). In vitro supplementation studies indicated that survival was highest in the 50%
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.